| | The variables | The patients (n = 903) |
| | Gender, n (%) | | Male | 821 (90.9%) | | Female | 82 (9.1%) | | Age (years), mean (SD) | 53.2 (12.3) | | HBsAg, n (%) | | Negative | 111 (12.3%) | | Positive | 792 (87.7%) | | Anti-HCV, n (%) | | Negative | 885 (98.0%) | | Positive | 82 (9.1%) | | HGB (g/L), mean (SD) | 132.5 (19.7) | | WBC (109/L), median (IQR) | 6.9 (5.2–9.3) | | PLT (109/L), median (IQR) | 144.1 (99.0–202.0) | | AST (U/L), median (IQR) | 65.8 (39.6–125.5) | | ALB (g/L), mean (SD) | 38.7 (5.7) | | TBLT(μmol/L), median (IQR) | 18.3 (12.6–27.1) | | CRP (mg/L), median (IQR) | 16.5 (3.4–55.4) | | PT (seconds), mean (SD) | 12.3 (1.3) | | AFP (ng/ml), median (IQR) | 242.3 (17.0–4447.5) | | Size of main tumor (mm), median (IQR) | 65.0 (43.0–95.5) | | Number of lesions, n (%) | | ≤3 | 360 (39.9%) | | >3 | 543 (60.1%) | | Ascites, n (%) | | No | 867 (96.0%) | | Little amount | 33 (3.6%) | | Middle amount | 3 (0.4%) | | Child–Pugh grade, n (%) | | A | 150 (16.6%) | | B | 753 (83.4%) | | ChildPugh score, n (%) | | ≤6 | 150 (16.6%) | | 7 | 629 (69.7%) | | 8 | 89 (9.9%) | | ≥9 | 35 (3.9%) | | ALBI score, mean (SD) | −2.4 (0.5) | | APRI score, median (IQR) | 1.5 (0.7–2.1) |
|
|
HCC, hepatocellular carcinoma; HCV, hepatitis C virus; HGB, hemoglobin; WBC, white blood cell; PLT, platelet; AST, aspartate aminotransferase; ALB, albumin; TBLT, total bilirubin; CRP, C-reactive protein; PT, prothrombin time; AFP, alpha-fetoprotein; ALBI, albumin-bilirubin grade; APRI, AST to platelet ratio index; SD, standard deviation; IQR, interquartile range.
|
